Long-Term Efficacy and Safety of Ustekinumab for Ulcerative Colitis: 4-Year Data from the UNIFI Maintenance Study

Update: 2024-07-16

Description

Philip Schoenfeld, MD, MSEd, MSc (Epi) and Rahul Dalal, MD, MPH discuss “Efficacy and safety of ustekinumab for ulcerative colitis through 4 years: final results of the UNIFI long-term maintenance study,” by Afif W, Arasaradnam RP, Abreu MT, Danese S, et al. Am J Gastroenterol 2024 May 1;119(5):910-921.

Comments

Top Podcasts

The Best New Comedy Podcast Right Now – June 2024 The Best News Podcast Right Now – June 2024 The Best New Business Podcast Right Now – June 2024 The Best New Sports Podcast Right Now – June 2024 The Best New True Crime Podcast Right Now – June 2024 The Best New Joe Rogan Experience Podcast Right Now – June 20 The Best New Dan Bongino Show Podcast Right Now – June 20 The Best New Mark Levin Podcast – June 2024

In Channel

Subcutaneous Infliximab for Maintenance of IBD Remission: Added Convenience with Potential for Improved Efficacy?

2024-11-1919:04

On-Demand Vonoprazan for Non-Erosive Reflux Disease Symptoms: A New Option

2024-11-1914:50

Suboptimal Adherence to Guidelines When Recommending Timing of Repeat Colonoscopy

2024-11-1915:40

Reintroducing Foods After Completing Restrictive Low FODMAP Diet

2024-11-1914:56

Quality Indicators for Colonoscopy: New Targets… But Will They Be Measured?

2024-10-2225:00

Decreasing Cirrhosis Risk in MASLD: Don’t Drink Alcohol!

2024-10-2210:33

A PPI a Day Keeps the GI Bleed Away in the ICU

2024-10-2212:33

A Laser Ruler to Hit the Mark on Polyp Size

2024-10-2214:22

ACG Guideline on Treatment of Helicobacter pylori: New Recommendations… Will Practice Change?

2024-09-1720:08

Risankizumab is Superior to Placebo for Induction and Maintenance of Moderate-Severe Ulcerative Colitis (UC): Assessing the UC Treatment Paradigm

2024-09-1716:38

Standardized Training for Endoscopic Mucosal Resection of Large Polyps: Does it Reduce Recurrence?

2024-09-1717:00

Diagnostic Yield of Prolonged Wireless pH vs 24-hour pH-Impedance Monitoring for Evaluation of Chronic Laryngeal Symptoms

2024-09-1720:12

Risankizumab is Superior to Ustekinumab for Induction and Maintenance of Crohn’s disease: The SEQUENCE Trial

2024-08-2021:59

Vonoprazan is Efficacious for Non-Erosive Reflux Disease (NERD): An Alternative for PPI-Resistant NERD Patients?

2024-08-2012:28

ERCP with Extracorporeal Shock-Wave Lithotripsy for Chronic Pancreatitis: Is It A “Sham” for Improving Pain?

2024-08-2011:25

ICYMI: ACG Clinical Guideline on Gastroparesis-Limited Evidence-Based Options

2024-08-2020:21

Tirzepatide Produces NASH Resolution and Decreases Fibrosis: Results from the SYNERGY-NASH Trial

2024-07-1610:07

Oral Vonoprazan for Prevention of High-Risk Peptic Ulcer Rebleeding: A Better Alternative than IV PPIs?

2024-07-1614:52

Long-Term Efficacy and Safety of Ustekinumab for Ulcerative Colitis: 4-Year Data from the UNIFI Maintenance Study

2024-07-1613:59

Do Not Extend Interval Between CRC Screening Colonoscopies from 10 to 15 Years: Perils of Administrative Databases

2024-07-1613:09

00:00

Long-Term Efficacy and Safety of Ustekinumab for Ulcerative Colitis: 4-Year Data from the UNIFI Maintenance Study

Philip Schoenfeld, MD, MSEd, MSc (Epi) and Rahul Dalal, MD, MPH

#box-pro-ellipsis-173245220297043{-webkit-line-clamp:2;}Long-Term Efficacy and Safety of Ustekinumab for Ulcerative Colitis: 4-Year Data from the UNIFI Maintenance Study

Long-Term Efficacy and Safety of Ustekinumab for Ulcerative Colitis: 4-Year Data from the UNIFI Maintenance Study

Philip Schoenfeld, MD, MSEd, MSc (Epi) and Rahul Dalal, MD, MPH

Long-Term Efficacy and Safety of Ustekinumab for Ulcerative Colitis: 4-Year Data from the UNIFI Maintenance Study